Cite

HARVARD Citation

    Poordad, F. et al. (2018). Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct‐acting antiviral treatment failure. Hepatology. 67 (4), pp. 1253-1260. [Online]. 
  
Back to record